Letter to the Editor in Response to ACG Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
- PMID: 36002917
- DOI: 10.14309/ajg.0000000000001967
Letter to the Editor in Response to ACG Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Comment in
-
Response to Haseeb et al.Am J Gastroenterol. 2022 Dec 1;117(12):2084-2085. doi: 10.14309/ajg.0000000000002004. Am J Gastroenterol. 2022. PMID: 36455224 No abstract available.
Comment on
-
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.Am J Gastroenterol. 2022 Jan 1;117(1):27-56. doi: 10.14309/ajg.0000000000001538. Am J Gastroenterol. 2022. PMID: 34807007 Free PMC article. Review.
References
-
- Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2022;117(1):27–56.
-
- Huang X, Chen S, Zhao H, et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: A systematic review with meta-analysis. Surg Endosc 2017;31(3):1032–44.
-
- Janu P, Shughoury AB, Venkat K, et al. Laparoscopic hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX device (HH + TIF): Efficacy and safety in two community hospitals. Surg Innov 2019;26(6):675–86.
-
- Trad KS, Barnes WE, Prevou ER, et al. The TEMPO trial at 5 years: Transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov 2018;25(2):149–57.
-
- Testoni S, Hassan C, Mazzoleni G, et al. Long-term outcomes of transoral incisionless fundoplication for gastro-esophageal reflux disease: Systematic-review and meta-analysis. Endosc Int Open 2021;09(02):E239–46.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
